American College of Cardiology and HOS establish strategic partnership

Mar 6 2010

A recently established a strategic partnership between the American College of Cardiology and Health Outcomes Sciences (HOS), signals a paradigm shift in the way healthcare is practiced.

“We are developing, as we speak, licensing agreements that will enable us to use our software to create evidence-based risk assessments for diabetes, cancer and other disease states”

The Kansas City-based HOS offers software solutions that make it possible to deliver individualized, evidence-based medicine at the point of care. Its capabilities will be showcased at the Hybrid Cath Lab/OR Suite exhibit at the ACC.10 and i2 Summit, March 14-16, in Atlanta, Ga.

“The HOS software is an exciting inclusion in our conference’s hybrid cath lab suite display,” says Henry A. Solomon, M.D., chief medical officer for business development at the American College of Cardiology. “HOS enables physicians and patients to better collaborate on treatment options and engage in shared decision-making that will improve outcomes, increase patient satisfaction and reduce healthcare costs overall.”

The strategic partnership between ACC and HOS grew naturally out of the two organizations’ focus on improving the quality of healthcare, not just in the cardiac cath lab but at every point of care. Using risk models collected from vast cardiovascular outcomes research, renowned cardiologist John Spertus, MD, MPh, developed ePrism™, software that translates complex risk models into fully functional decision-support tools for physicians, as well as personalized educational and informed consent documents for patients. Dr. Spertus has been successfully employing the software at Saint Luke’s Mid America Heart Institute, where he is director of Cardiovascular Outcomes Research.

“Even the sharpest physicians today struggle to synthesize all the information available about possible survival rates, risk factors and future outcomes for certain patients,” said Dr. Spertus. “By establishing that we could generate risk analyses for potential complications, including mortality, bleeding and restenosis, we set the stage for development of these evidence-based risk models in every area of medicine.”

HOS was formed to do just that: expand the use of these software solutions beyond the cath lab and into risk assessments that are procedure and care-setting agnostic.

“We are developing, as we speak, licensing agreements that will enable us to use our software to create evidence-based risk assessments for diabetes, cancer and other disease states,” said Jim Wilson, HOS chief executive officer. “Our vision is to have these tools available to doctors and their patients at every point of care.”

Source American College of Cardiology